VIR
Income statement / Annual
Last year (2023), Vir Biotechnology, Inc.'s total revenue was $86.18 M,
a decrease of 94.55% from the previous year.
In 2023, Vir Biotechnology, Inc.'s net income was -$615.06 M.
See Vir Biotechnology, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$86.18 M |
$1.58 B |
$1.09 B |
$67.25 M |
$711,000.00 |
$868,000.00 |
$149,000.00 |
Cost of Revenue |
$2.77 M
|
$146.32 M
|
$65.87 M
|
$301.58 M
|
$148.47 M
|
$100.23 M
|
$62.51 M
|
Gross Profit |
$83.42 M
|
$1.43 B
|
$1.02 B
|
-$234.33 M
|
-$147.76 M
|
-$99.36 M
|
-$62.36 M
|
Gross Profit Ratio |
0.97
|
0.91
|
0.94
|
-3.48
|
-207.82
|
-114.47
|
-418.54
|
Research and Development Expenses |
$589.67 M
|
$474.65 M
|
$448.01 M
|
$302.41 M
|
$148.47 M
|
$100.23 M
|
$62.51 M
|
General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$70.94 M
|
$37.60 M
|
$29.13 M
|
$21.69 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$174.05 M
|
$161.76 M
|
$160.79 M
|
$70.94 M
|
$37.60 M
|
$29.13 M
|
$21.69 M
|
Other Expenses |
$0.00
|
-$35.33 M
|
-$8.35 M
|
-$9.12 M
|
-$7.38 M
|
-$212,000.00
|
$83,000.00
|
Operating Expenses |
$767.72 M
|
$601.09 M
|
$600.45 M
|
$364.23 M
|
$178.69 M
|
$119.56 M
|
$81.65 M
|
Cost And Expenses |
$770.49 M
|
$747.40 M
|
$666.32 M
|
$364.23 M
|
$178.69 M
|
$119.56 M
|
$81.65 M
|
Interest Income |
$86.99 M
|
$28.09 M
|
$439,000.00
|
$2.84 M
|
$8.51 M
|
$2.54 M
|
$638,000.00
|
Interest Expense |
$0.00
|
$183.15 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$19.45 M
|
$15.49 M
|
$11.98 M
|
$8.81 M
|
$4.52 M
|
$2.76 M
|
$432,000.00
|
EBITDA |
-$664.85 M |
$833.07 M |
$420.75 M |
-$289.80 M |
-$173.46 M |
-$115.94 M |
-$81.07 M |
EBITDA Ratio |
-7.71
|
0.6
|
0.26
|
-4.42
|
-250.32
|
-133.57
|
-544.06
|
Operating Income Ratio |
-7.94
|
0.53
|
0.25
|
-4.42
|
-250.32
|
-136.74
|
-546.96
|
Total Other Income/Expenses Net |
$56.11 M
|
-$78.79 M
|
$129.05 M
|
-$1.63 M
|
$3.45 M
|
$2.33 M
|
$721,000.00
|
Income Before Tax |
-$628.19 M
|
$754.28 M
|
$549.80 M
|
-$298.61 M
|
-$174.53 M
|
-$116.36 M
|
-$80.78 M
|
Income Before Tax Ratio |
-7.29
|
0.48
|
0.51
|
-4.44
|
-245.47
|
-134.06
|
-542.12
|
Income Tax Expense |
-$13.08 M
|
$238.44 M
|
$21.22 M
|
$54,000.00
|
$154,000.00
|
-$480,000.00
|
-$10.92 M
|
Net Income |
-$615.06 M
|
$515.84 M
|
$528.58 M
|
-$298.67 M
|
-$174.68 M
|
-$115.88 M
|
-$69.85 M
|
Net Income Ratio |
-7.14
|
0.33
|
0.49
|
-4.44
|
-245.69
|
-133.51
|
-468.81
|
EPS |
-4.59 |
3.89 |
4.07 |
-2.51 |
-1.62 |
-1.2 |
-0.72 |
EPS Diluted |
-4.59 |
3.83 |
3.96 |
-2.51 |
-1.62 |
-1.2 |
-0.72 |
Weighted Average Shares Out |
$134.13 M
|
$132.61 M
|
$129.88 M
|
$119.16 M
|
$107.65 M
|
$96.91 M
|
$96.91 M
|
Weighted Average Shares Out Diluted |
$134.13 M
|
$134.81 M
|
$133.44 M
|
$119.16 M
|
$107.65 M
|
$96.91 M
|
$96.91 M
|
Link |
|
|
|
|
|
|
|